Evidence map›Paper›PMID 22924123›Full record

ArticleAutoimmune diseases2012

Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators.

Claudio Blasi, Eunjung Kim, Anne A Knowlton

Open access · goldAbstract read
In one paragraph

Article in Autoimmune diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Diabetes, Protein Misfolding, and Heat Stress: Molecular Insights and Translational Perspectives.TH open : companion journal to thrombosis and haemostasis · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cardiac myocyte exosomes: stability, HSP60, and proteomics.American journal of physiology. Heart and circulatory physiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Claudio BlasiCentro Diabete, ASL RMB-1D, L.go T. Solera n.7, Rome, Italy.
Eunjung Kim
Anne A Knowlton
Daejeon Catholic University · KRUC Davis Health · US

Funding

Human Cardiomyopathy and HSP60R01HL077281 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI KNOWLTON, ANNE A · 2004 to 2012
$3.1M
HSPs, Inflammatory Response and Cardiovascular DiseaseR01HL079071 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOWLTON, ANNE A · 2006 to 2014
$2.7M
NHLBI NIH HHS R01 HL077281NHLBI NIH HHS R01 HL079071
6 · The paper itself

Abstract

The diabetes-atherosclerosis relationship remains to be fully defined. Repeated prolonged hyperglycemia, increased ROS production and endothelial dysfunction are important factors. One theory is that increased blood levels of heat shock protein (HSP)60 are proinflammatory, through activation of innate immunity, and contribute to the progression of vascular disease. It was hypothesized that improvement of diabetes control in patients presenting with metabolic syndrome would lower HSP60, and anti-HSP60 antibody levels and decrease inflammatory markers. Paired sera of 17 Italian patients, before and after intensive treatment, were assayed for cytokines, HSP60 and anti-HSP60 antibodies. As expected, intensive treatment was associated with a decrease in HgbA1C (P < 0.001) and BMI (P < 0.001). After treatment, there was a significant decrease in IL-6 (P < 0.05). HSP60 levels were before treatment -6.9 + 1.9, after treatment -7.1 + 2.0 ng/mL (P = ns). Overall HSP60 concentrations were lower than published reports. Anti-HSP60 antibody titers were high and did not decrease with treatment. In conclusion, improvement of diabetic control did not alter HSP60 concentrations or antiHSP60 antibody titers, but led to a reduction of IL-6 levels.

Identifiers

PMID22924123
PMCPMC3424633
OpenAlexW1997646251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.